ImmunoGenesis
Develops science-driven immune therapies specifically designed to treat tumors lacking activated T cells or having other immune resistance mechanisms.
Employees
Enterprise value
$18—27m
loading funding rounds…
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads